Considering Needle Phobia among Adult Patients During Mass COVID-19 Vaccinations
Author(s) -
Ashley S. Love,
Robert J. Love
Publication year - 2021
Publication title -
journal of primary care and community health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.55
H-Index - 19
eISSN - 2150-1327
pISSN - 2150-1319
DOI - 10.1177/21501327211007393
Subject(s) - herd immunity , medicine , vaccination , pandemic , population , health care , covid-19 , family medicine , environmental health , immunology , disease , pathology , infectious disease (medical specialty) , economics , economic growth
As mass vaccination is underway to combat the COVID-19 pandemic and achieve herd immunity, healthcare professionals need to recognize the fear and phobia of needles among their patients. Approximately 11.5 to 66 million U.S. adults may suffer from this condition. This population often avoids seeking medical care including vaccinations. The exact number of people suffering from this phobia is unknown, and the potential years of life lost in the American health care system cannot be estimated accurately. The resistance to vaccinations among this population may delay achieving herd immunity to end this current pandemic. An overview of needle phobia, vaccinations, and current treatments are explored. The use of telemedicine could prove critical for reaching this population as well as those who are hesitant about vaccinations. Providing education to healthcare providers to identify and manage these patients during the pandemic is necessary.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom